Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK

Trial Profile

Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2014

At a glance

  • Drugs Quetiapine (Primary) ; Antidepressants; Antipsychotics
  • Indications Bipolar depression; Major depressive disorder; Schizophrenia
  • Focus Adverse reactions
  • Acronyms GPRD-SeroquelS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Feb 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
    • 07 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top